Roche Holding AGRHHVF
13F holders, Q2 2026 (June 30)2holders
0new positions
0sold out
$412.55avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Roche Holding AG (RHHVF) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($85.3M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.5M).
- Company
- Roche Holding AG
- CUSIP
- H69293266
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 11,387 shares sold, net −11,387 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.18% | Reduce -5.0% | 206,871 | $85.3M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.12% | Reduce -8.8% | 6,123 | $2.5M |
"% of holder's portfolio" is RHHVF's weight in each manager's 13F, not the share of Roche Holding AG the manager owns.